These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3944476)

  • 1. High yield monoclonal antibody production in ascites.
    Brodeur BR; Tsang PS
    J Immunol Methods; 1986 Feb; 86(2):239-41. PubMed ID: 3944476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ascites production for monoclonal antibodies in BALB/c and BALB/c-derived cross-bred mice.
    Stewart F; Callander A; Garwes DJ
    J Immunol Methods; 1989 May; 119(2):269-75. PubMed ID: 2542413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameters affecting ascites tumour formation in mice and monoclonal antibody production.
    Brodeur BR; Tsang P; Larose Y
    J Immunol Methods; 1984 Jul; 71(2):265-72. PubMed ID: 6736661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of severe combined immunodeficient (SCID) mice to produce human hybridoma ascites.
    McKnight ME; Prather K; Koda K; DeBoer KF; Glassy MC
    Hum Antibodies Hybridomas; 1991 Oct; 2(4):190-3. PubMed ID: 1751782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody production in murine ascites. II. Production characteristics.
    Jackson LR; Trudel LJ; Fox JG; Lipman NS
    Lab Anim Sci; 1999 Feb; 49(1):81-6. PubMed ID: 10090099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody production by hybridoma growth in Freund's adjuvant primed mice.
    Mueller UW; Hawes CS; Jones WR
    J Immunol Methods; 1986 Mar; 87(2):193-6. PubMed ID: 3950429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved efficiency of hybridoma ascites production by intrasplenic inoculation in mice.
    Witte PL; Ber R
    J Natl Cancer Inst; 1983 Mar; 70(3):575-7. PubMed ID: 6339777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody production in murine ascites. I. Clinical and pathologic features.
    Jackson LR; Trudel LJ; Fox JG; Lipman NS
    Lab Anim Sci; 1999 Feb; 49(1):70-80. PubMed ID: 10090098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production in ascites fluid of biosynthetically labelled monoclonal antibody to Theileria parva sporozoites.
    Dobbelaere DA; Spooner PR
    J Immunol Methods; 1985 Oct; 82(2):209-14. PubMed ID: 3930611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The possibility of using outbred mice for the production of monoclonal antibodies].
    Novikov VV; Trofimova MN; Dubinkin IV; Komarova OB; Biriukova LZ
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):81-4. PubMed ID: 2816186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Passage of hybridomas in male BALB/c mice].
    Novikov VV; Trofimova MN; Zhil'tsova MA; Biriukova LZ
    Antibiot Khimioter; 1988 Nov; 33(11):836-8. PubMed ID: 3228324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of rat-mouse hybridomas in nude mice and nude rats.
    Noeman SA; Misra DN; Yankes RJ; Kunz HW; Gill TJ
    J Immunol Methods; 1982 Dec; 55(3):319-26. PubMed ID: 6762397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of large quantities of human immunoglobulin in the ascites of athymic mice: implications for the development of anti-human idiotype monoclonal antibodies.
    Abrams PG; Ochs JJ; Giardina SL; Morgan AC; Wilburn SB; Wilt AR; Oldham RK; Foon KA
    J Immunol; 1984 Apr; 132(4):1611-3. PubMed ID: 6699400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimal production of murine monoclonal antibodies in ascites of syngeneic mice by a single whole body irradiation].
    Witt S; Ziegler B; Klöting I; Nadrowitz R; Schmidt W; Ziegler M
    Allerg Immunol (Leipz); 1987; 33(4):259-64. PubMed ID: 2964179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatives to pristane priming for ascitic fluid and monoclonal antibody production.
    Gillette RW
    J Immunol Methods; 1987 May; 99(1):21-3. PubMed ID: 3571991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pristane on ascites tumor formation and monoclonal antibody production.
    Hoogenraad NJ; Wraight CJ
    Methods Enzymol; 1986; 121():375-81. PubMed ID: 3724477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pre-injection of mice with pristane on ascites tumour formation and monoclonal antibody production.
    Hoogenraad N; Helman T; Hoogenraad J
    J Immunol Methods; 1983 Jul; 61(3):317-20. PubMed ID: 6875258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass production of monoclonal antibody in an ICR mouse using hybridoma cell lines MAC-1 and Aq-12 yields 165 mL ascitic fluid.
    Hasegawa N; Watanabe M; Ohno T
    Hybridoma; 2000 Apr; 19(2):191-2. PubMed ID: 10868801
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased monoclonal antibody ascites production in mice primed with Freund's incomplete adjuvant.
    Jones SL; Cox JC; Pearson JE
    J Immunol Methods; 1990 May; 129(2):227-31. PubMed ID: 2351839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat monoclonal antibodies. VII. Enhancement of ascites production and yield of monoclonal antibodies in rats following pretreatment with pristane and Freund's adjuvant.
    Kints JP; Manouvriez P; Bazin H
    J Immunol Methods; 1989 May; 119(2):241-5. PubMed ID: 2723442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.